Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-010523
Filing Date
2022-07-05
Accepted
2022-07-05 08:53:10
Documents
3
Period of Report
2022-08-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A ampe-20220810xdef14a.htm DEF 14A 709432
2 GRAPHIC ampe-20220810xdef14a013.jpg GRAPHIC 138565
3 GRAPHIC ampe-20220810xdef14a014.jpg GRAPHIC 113254
  Complete submission text file 0001558370-22-010523.txt   1057644
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35182 | Film No.: 221063312
SIC: 2834 Pharmaceutical Preparations